Neodopasol combination tablets (YJ code: 1169100F1060, standard: 1 tablet) are manufactured by Alfresa Pharma. This medication combines levodopa, which converts to dopamine in the brain, with benserazide hydrochloride, a peripheral decarboxylase inhibitor, to treat Parkinson’s disease and Parkinsonian syndrome.
Neodopasol combination tablets
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
